Surgery Partners, Inc. (SGRY) › Shareholders' EquitySurgery Partners, Inc. (SGRY) — Shareholders' EquityAnnual figures by period end, from SEC filings.2012-12-31: $124.11M2013-12-31: -$14.38M2014-12-31: $29.54M2015-12-31: $297.93M2016-12-31: $324.70M2017-08-31: $480.00M2017-09-01: $1.41B2017-12-31: $1.34B2018-12-31: $1.10B2019-12-31: $983.40M2020-12-31: $882.10M2021-12-31: $1.97B2022-12-31: $2.94B2023-12-31: $3.03B2024-12-31: $3.20B2025-12-31: $3.13B$3.13B2012-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$3.13B-2.0%2026-03-02Balance as of period end2024-12-31$3.20B+5.3%2026-03-02Balance as of period end2023-12-31$3.03B+3.2%2026-03-02Balance as of period end2022-12-31$2.94B+49.3%2026-03-02Balance as of period end2021-12-31$1.97B+123.3%2025-03-07Balance as of period end2020-12-31$882.10M-10.3%2024-02-26Balance as of period end2019-12-31$983.40M-10.5%2023-03-01Balance as of period end2018-12-31$1.10B-17.8%2022-03-01Balance as of period end2017-12-31$1.34B—2021-03-10Balance as of period end2017-09-01$1.41B—2020-03-13Balance as of period end2017-08-31$480.00M—2020-03-13Balance as of period end2016-12-31$324.70M+9.0%2020-03-13Balance as of period end2015-12-31$297.93M+908.7%2017-03-10Balance as of period end2014-12-31$29.54M—2017-03-10Balance as of period end2013-12-31-$14.38M-111.6%2017-03-10Balance as of period end2012-12-31$124.11M—2016-03-11Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)